Diabetes Scorecard Educational Intervention Study

Type 2 Diabetes Clinical Trial

Official title:

Use of a Card to Improve Risk Factor Control in Patients With Type II Diabetes

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01339520
• Other study ID #: DiabetesScorecardStudy
• Status: Completed
• Phase: N/A
• First received: April 19, 2011
• Last updated: August 10, 2017
• Start date: November 2008
• Est. completion date: May 2010

Study information

• Verified date: August 2017
• Source: George Washington University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to see if the use of a diabetic scorecard during clinic visits can improve glycemic control, blood pressure control, LDL-cholesterol, aspirin usage, and amount of exercise in adults over age 40 with uncontrolled Type II diabetes.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 104
• Est. completion date: May 2010
• Est. primary completion date: May 2010
• Accepts healthy volunteers: No
• Gender: All
• Age group: 40 Years and older

Eligibility

Inclusion Criteria:

• Uncontrolled Type II diabetes (HbA1c = 8%)

Exclusion Criteria:

• Type I Diabetes

• HbA1c < 8%

• Inability to understand the diabetes scorecard due to condition (i.e. dementia, mental retardation, etc) or language barrier

• Pregnancy

• Planning to move within the next year

Related Conditions & MeSH terms

• Diabetes Mellitus
• Type 2 Diabetes

Intervention

Behavioral:
• Scorecard
Points were assigned for blood pressure, HbA1c level, LDL-cholesterol level, aspirin use and exercise level.
• Control
Standard of care for diabetes subjects

Locations

Country	Name	City	State
United States	Medical Faculty Associates, George Washington University	Washington, D.C.	District of Columbia

Sponsors (1)

Lead Sponsor	Collaborator
George Washington University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in total score	The total score was calculated by points assigned to variables (systolic blood pressure, diastolic blood pressure, HbA1c, aspirin usage and daily exercise). The maximal score of 100 corresponds to all variables at target. Fewer points were assigned to higher blood pressure, worse HbA1c levels, less exercise, etc.	9 months
Secondary	LDL-cholesterol		9 months
Secondary	HbA1c	Measure of glycemic control	9 months